Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Up 657.6% in November

Envoy Medical, Inc. (NASDAQ:COCH) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 355,300 shares, a growth of 657.6% from the October 31st total of 46,900 shares. Based on an average daily volume of 231,200 shares, the short-interest ratio is currently 1.5 days. Approximately 4.6% of the shares of the company are short sold.

Envoy Medical Stock Performance

COCH stock traded up $0.08 during trading on Wednesday, hitting $2.29. The company had a trading volume of 17,804 shares, compared to its average volume of 200,449. The firm has a 50-day moving average price of $2.63 and a 200-day moving average price of $2.61. Envoy Medical has a 12 month low of $1.08 and a 12 month high of $11.46.

Institutional Investors Weigh In On Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC acquired a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned 0.07% of Envoy Medical at the end of the most recent quarter. 8.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on COCH shares. Ascendiant Capital Markets boosted their price target on shares of Envoy Medical from $8.50 to $8.75 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Brookline Capital Management started coverage on shares of Envoy Medical in a research note on Monday, October 14th. They set a “buy” rating and a $9.00 price target for the company.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.